| human | Q5 |
| P269 | IdRef ID | 075019663 |
| P213 | ISNI | 0000000033979914 |
| P8189 | National Library of Israel J9U ID | 987007604714105171 |
| P691 | NL CR AUT ID | ntk20211127362 |
| P496 | ORCID iD | 0000-0002-8576-6093 |
| P214 | VIAF ID | 59331969 |
| P108 | employer | Indiana University School of Medicine | Q2123017 |
| P101 | field of work | pathology | Q7208 |
| liver disease | Q929737 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | scientist | Q901 |
| university teacher | Q1622272 | ||
| P21 | sex or gender | male | Q6581097 |
| Q79961073 | A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells |
| Q104457177 | A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 |
| Q34581082 | BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs. |
| Q34987859 | Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. |
| Q21996341 | Guidelines for the use and interpretation of assays for monitoring autophagy |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q90296417 | Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury |
Search more.